Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Summit Therapeutics (US:SMMT) Seeking Alpha·2026-01-12 20:56PresentationMahkam ZanganehCo-CEO, President & Director Good afternoon. Thank you for joining us today, and thank you for JPMorgan for having us today to present at this conference. I'm Dr. Maky Zanganeh, President and Co-CEO at Summit Therapeutics; Bob Duggan, Chairman and CEO at Summit Therapeutics. I'm honored to go over the latest update for Summit, our lead asset, ivonescimab as well as reviewing our upcoming catalysts for what we believe will be a positive transformative year for Summit in 2026. Summi ...